Selecting a Favorable KIR Donor in Unrelated HCT for AML
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Weisdorf, M.D.
Masonic Cancer Center, University of Minnesota
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic - Scottsdale
Scottsdale, Arizona, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Emory University
Atlanta, Georgia, United States
- University of Chicago Medical Center Cancer Center
Chicago, Illinois, United States
- Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
- Kansas University Cancer Center
Kansas City, Kansas, United States
- Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- New York Presbyterian Weill Cornell Medical Center
New York, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Baylor Sammons Cancer Center
Dallas, Texas, United States
- M.D. Anderson Cancer Center
Houston, Texas, United States
- Methodist Healthcare System of San Antonio
San Antonio, Texas, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2011
- Primary completion
- 30 Apr 2020
- Completion
- 30 Apr 2020
- Last update posted
- 11 Mar 2021
- Registered enrollment
- 506
- Registry id
- NCT01288222
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.